Endovascular repair for arterio-venous fistula treatment: a case report

Abstract

Background

Arterio-venous fistula is a rare clinical entity that occurs as a result of a ruptured abdominal aortic aneurysm into the inferior vena cava or iliac vein. Open surgery has been considered the treatment of choice for this condition; however, endovascular repair has become an evolving therapeutic option over the past 20 years. The endovascular treatment has contributed to a decrease in the perioperative mortality; nevertheless, some endovascular repair specific concern for residual fistula still remains.

Case presentation

A 70-year-old man was referred to our department for an enlarged inferior vena cava without any complaint. Contrast-enhanced computed tomography demonstrated a 40-mm AAA and a 42-mm right saccular CIAA, with a fistula between the CIAA and left CIV. Endovascular aneurysm repair which focused on the exclusion of the right CIAA and prevention of endoleak formation was performed. To prevent type 2 endoleaks, which cause residual arterio-venous shunt flow, right internal iliac artery was embolized with a vascular plug prior to stent graft procedure. Successful aneurysm exclusion without residual arterio-venous shunt flow was confirmed with a final angiographic examination. The patient had an uneventful recovery, and computed tomography 1 month later showed no sign of persistent fistula.

Conclusions

Although endovascular treatment for AVF has a negative possibility of residual shunt, stent graft with a focus on type 2 endoleak prevention can be an attractive treatment option, reducing the incidence of residual AVF.

Background

Arterio-venous fistula (AVF) is a rare clinical entity, which is reported in 2–7% of ruptured abdominal aortic aneurysms (rAAAs) [1]. Eighty percent of patients with AVF exhibit erosion of the arterial wall and spontaneous shunting of the arterial blood into the adjacent vena cava or, less often, to the right iliac vein [2]. AVF results in major hemodynamic changes induced by the diversion of blood flow from the arterial to venous circulation. This process increases the venous pressure, thereby causing acute high-output heart failure [3]. Although urgent AVF repair is required to achieve hemostasis in the context of rAAAs, drastic hemodynamic changes should be avoided as they could cause lethal circulatory dysfunction [2].

AVF is classically treated via open surgical repair; however, there are reports of significant intraoperative bleeding and high morbidity and mortality rates associated with this intervention [3]. Over the past 20 years, endovascular aortic aneurysm repair (EVAR), a less invasive technique, has evolved into an alternative therapeutic option for patients with AVF [4]. EVAR provides an adequate, validated, and safe therapeutic option for AVF, with lower mortality rates [2]. However, several cases of postoperative endoleaks associated with persistent residual AVF have been reported [1]. Herein, we present a case of a ruptured right common iliac arterial aneurysm (CIAA) with a fistula to the left common iliac vein (CIV), which was managed by endovascular repair. The patient provided informed consent for the publication of this case report.

Case presentation

A 70-year-old man was referred to our department for an enlarged inferior vena cava with early phase contrast enhancement seen on computed tomography (CT). He previously underwent percutaneous coronary intervention (PCI) via the left radial artery for three-vessel disease 6 months prior to admission. He had repeated episodes of post PCI heart failure, for which he was admitted to the cardiology ward of our hospital. Contrast-enhanced CT demonstrated a 40-mm AAA and a 42-mm right saccular CIAA, with a fistula between the CIAA and left CIV (Fig. 1A). Physical examination revealed lower limb edema and a pulsatile abdominal mass with vascular thrill; however, no clinical signs of respiratory failure or laboratory findings indicative of liver or renal dysfunction noted on admission. The patient was stable based on clinical and radiographic findings and was consequently scheduled for elective endovascular repair.

Fig. 1

Preoperative three-dimensional reconstruction of computed tomography angiography and initial intraoperative angiography findings A Preoperative three-dimensional reconstruction of computed tomography angiography showing a 40-mm abdominal aortic aneurysm, 40-mm right common iliac arterial aneurysm with ilio-iliac fistula (black arrow), and severely dilated inferior vena cava (white arrow). B Intraoperative initial angiography showing a communication between the right iliac artery and left iliac vein (black arrow), as well as a severely dilated inferior vena cava (white arrow)

The surgery was performed under general anesthesia using a bilateral femoral arterial approach (Fig. 1B). Preoperatively, a venous cannula was inserted into the inferior vena cava (IVC) via the left femoral vein to monitor intraoperative hemodynamic changes and ascertain complete fistula exclusion after endograft deployment. Preoperative CT and intraoperative angiography revealed that the origin of the AVF was the right CIAA. Thus, the operative strategy focused on the exclusion of the right CIAA and prevention of endoleak formation. The absence of arterial branches such as lumber artery or media sacral artery which could cause type 2 endoleaks was checked carefully on preoperative CT scan and intraoperative angiography. To prevent type 2 endoleaks from internal iliac arterial back-bleeding, right internal iliac artery embolization was performed using an Amplatzer Vascular Plug 2 (St. Jude Medical, Saint Paul, MN, USA). A straight graft (Excluder leg device; 16 $\times$ 12 $\times$ 120 mm; W. L. Gore & Assoc., Flagstaff, AZ, USA) was deployed from a sealable, non-dilated portion of the proximal right common iliac artery to the external iliac artery, effectively excluding the right CIAA and rendering it independent from the AAA. AAA exclusion was then performed following CIAA exclusion. Total aneurysm exclusion was achieved by deploying an Excluder main body stent graft from just below the renal artery to the right external and left common iliac arteries. Finally, a straight graft (Excluder leg device, 16 $\times$ 16 $\times$ 140 mm) was placed between the main body of the device and the first right iliac straight graft, thereby completing aneurysm exclusion.

As planned, successful aneurysm exclusion without residual arterio-venous shunt flow was confirmed using a final angiographic examination (Fig. 2A). Pre-deployment pressure monitoring at the IVC showed an arterial pulsatile wave pattern ranging from 10 to 11 mmHg. After stent graft deployment, the shape of the pressure curve changed into a continuous flow curve similar to the normal venous pressure curve, and the pressure decreased to 6 mmHg. Conversely, the systolic systemic pressure fluctuated, temporarily increasing to 131 mmHg and then dropping to 81 mmHg. However, the cardiac index was maintained, and hemodynamic parameters subsequently stabilized. The patient was asymptomatic during the postoperative period, and no significant complications were noted. The lower extremity edema gradually resolved after surgery. One-month postoperative CT confirmed complete aneurysm exclusion without type 2 endoleak (Fig. 2B). The CIAA and CIV were remodeled and shrunk, and the diameters were decreased from 42 to 29 mm and from 26 to 15 mm. There were no signs of persistent AVF or pulmonary embolization.

Fig. 2

Final intraoperative angiography and postoperative three-dimensional reconstruction of computed tomography angiography findings A Intraoperative final angiography confirming the absence of persistent arterio-venous fistula and significant endoleak. B Postoperative three-dimensional reconstruction of computed tomography angiography performed one month after surgery showing complete aneurysm exclusion and fistula dissipation

Discussion

AVF was first reported in 1831, and the first successful open surgical repair was described by Cooley et al. in 1955 [5]. Despite high surgical morbidity and mortality rates, patients with AVF continued to undergo open surgical repair [3]. However, since the first endovascular AVF repair was described by Beveridge et al. in 1998 [4], an alternative intervention has been recognized. Several studies on endovascular AVF treatment have since been published. In 2021, Borghese et al. conducted a systematic review on 46 and 33 patients who underwent open and endovascular repairs, respectively, between 1999 and 2018. The 30-day mortality rates in the open and endovascular repair groups were 10.8% and 3.0%, respectively [3]. These results supported the use of the endovascular method for AVF repair to reduce the risk of complications and death.

Although endovascular surgery seems to be a good therapeutic option with low risks of morbidity and mortality, it is associated with several specific concerns, such as the possibility of residual AVF. Melas et al. described a case of a patient with residual AVF after EVAR. Although the patient was stable 6 months after surgery, the AVF increased in size and the patient presented with signs of progressing heart failure [6]. Most of these persistent fistulas are considered to be associated with type 2 endoleaks, which may occur in up to 50% of patients treated by EVAR [1]. Further, the assessment and management of persistent AVF due to type 2 endoleak after endovascular treatment is controversial. Minimal shunt flow may be clinically insignificant; however, a significant shunt flow can cause heart failure and require therapeutic intervention. Nakad et al. conducted a systematic review wherein they reported that 11% of patients with persistent AVF due to type 2 endoleak required reintervention [7]. Moreover, some authors recommend venous stent-graft insertion in patients with the abovementioned condition. Conversely, considering that 89% of patients with persistent AVF would not require additional intervention, a small residual shunt would not always yield adverse effects [8]. Wang et al. showed that residual AVF causes a pressure gradient because of its connection with the low-pressure venous system, resulting in decreased in-sac pressure [8]. Therefore, the aneurysm sac and fistula orifice may shrink gradually under the low in-sac pressure. Luijtgaarden et al. also emphasized that type 2 endoleaks could resolve spontaneously [9]. They presented a case of a patient with aneurysm sac shrinkage resulting from residual AVF at 1 year after EVAR. A comprehensive review of the relevant published studies was undertaken and the results were shown in Table 1, including the cases referred to here [7, 9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42].

Table 1 Summary of AVF cases treated with EVAR

Although most persistent trivial fistula shunts do not present with severe symptoms or resolve spontaneously, Fujimiya et al. emphasized the risks of AVF-specific complications following EVAR [43]. They presented a case of a patient with a type 2 endoleak from the inferior mesenteric artery (IMA), which coexisted with a persistent AVF after EVAR. Four months after EVAR for AVF, there was an occurrence of spontaneous AVF obstruction and subsequent rapid aneurysm sac dilatation due to the type 2 endoleak. Direct ligation of the IMA via median laparotomy was required, highlighting that EVAR alone is insufficient for AVF treatment where IMA or large lumbar arteries are involved. In our case, the AVF involved the CIAA and had no arterial branches. Thus, the probability of developing a type 2 endoleak was considerably low, and we determined that treatment using a stent graft without embolization except for the internal iliac artery was possible, which was achieved successfully. However, in cases where the aneurysm has arterial branches that can cause endoleaks, additional procedures such as embolization should be performed.

Although endovascular treatment has specific concerns, it is widely recognized as a less invasive alternative to open surgery. In contrast to non-ruptured AAA, type 2 endoleak can occur residual AVF, which can affect patient outcomes. Thus, reliable coiling should be applied for large IMA or lumbar arteries to prevent type 2 endoleak occurrence. We believe that endovascular surgery with a focus on type 2 endoleak prevention would reduce the incidence of residual AVF, thus improving the outcomes of patients with AVF.

We present the successful repair of a ruptured right CIAA with a fistula to the left CIV using an endovascular graft. We believe the endovascular repair can be an attractive treatment option for the AVF, provided the type 2 endoleak is effectively prevented.